Historic 1st: FDA calls for opioid to be removed from market based on risk of abuse 

sentinelblog

Source: Historic 1st: FDA calls for opioid to be removed from market based on risk of abuse — RT America

Historic 1st: FDA calls for opioid to be removed from market based on risk of abuse © Ali Jarekji / Reuters

In an unprecedented move, the US Food and Drug Administration has requested a drugmaker withdraw an opioid pain medicine from the market due to its potential for abuse. The agency cited the current “opioid epidemic” as a catalyst for the move.

The FDA has targeted the reformulated version of Opana ER, or oxymorphone hydrochloride, for market removal, calling on its manufacturer, Ireland-based Endo Pharmaceuticals, to take voluntary steps to do so.

If Endo chooses not to withdraw Opana ER ‒ first approved by the FDA in 2006 – the federal agency said it would take steps to rescind its approval of the drug.

“We are facing an opioid epidemic ‒ a public health crisis, and we must take all necessary steps to reduce the scope of…

View original post 543 more words

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s